Switzerland · Delayed Price · Currency is CHF Newron Pharmaceuticals Statistics
Total Valuation
SWX:NWRN has a market cap or net worth of CHF 286.24 million. The enterprise value is 294.99 million.
| Market Cap | 286.24M |
| Enterprise Value | 294.99M |
Important Dates
The next estimated earnings date is Thursday, December 18, 2025.
| Earnings Date | Dec 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:NWRN has 19.96 million shares outstanding. The number of shares has increased by 16.86% in one year.
| Current Share Class | 19.96M |
| Shares Outstanding | 19.96M |
| Shares Change (YoY) | +16.86% |
| Shares Change (QoQ) | -11.63% |
| Owned by Insiders (%) | 4.81% |
| Owned by Institutions (%) | 6.02% |
| Float | 19.00M |
Valuation Ratios
The trailing PE ratio is 12.90.
| PE Ratio | 12.90 |
| Forward PE | n/a |
| PS Ratio | 5.12 |
| PB Ratio | 193.73 |
| P/TBV Ratio | 193.85 |
| P/FCF Ratio | 12.49 |
| P/OCF Ratio | 12.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.93, with an EV/FCF ratio of 12.88.
| EV / Earnings | 12.47 |
| EV / Sales | 5.27 |
| EV / EBITDA | 8.93 |
| EV / EBIT | 8.97 |
| EV / FCF | 12.88 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 33.23.
| Current Ratio | 1.51 |
| Quick Ratio | 1.40 |
| Debt / Equity | 33.23 |
| Debt / EBITDA | 1.49 |
| Debt / FCF | 2.14 |
| Interest Coverage | 8.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 50.97% |
| Return on Invested Capital (ROIC) | 60.97% |
| Return on Capital Employed (ROCE) | 165.16% |
| Revenue Per Employee | 2.54M |
| Profits Per Employee | 1.08M |
| Employee Count | 22 |
| Asset Turnover | 1.39 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SWX:NWRN has paid 5.19 million in taxes.
| Income Tax | 5.19M |
| Effective Tax Rate | 17.99% |
Stock Price Statistics
The stock price has increased by +57.02% in the last 52 weeks. The beta is 0.75, so SWX:NWRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +57.02% |
| 50-Day Moving Average | 10.51 |
| 200-Day Moving Average | 8.63 |
| Relative Strength Index (RSI) | 61.87 |
| Average Volume (20 Days) | 203,365 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:NWRN had revenue of CHF 55.93 million and earned 23.65 million in profits. Earnings per share was 1.11.
| Revenue | 55.93M |
| Gross Profit | 55.93M |
| Operating Income | 32.88M |
| Pretax Income | 28.84M |
| Net Income | 23.65M |
| EBITDA | 32.89M |
| EBIT | 32.88M |
| Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 40.34 million in cash and 49.10 million in debt, giving a net cash position of -8.75 million or -0.44 per share.
| Cash & Cash Equivalents | 40.34M |
| Total Debt | 49.10M |
| Net Cash | -8.75M |
| Net Cash Per Share | -0.44 |
| Equity (Book Value) | 1.48M |
| Book Value Per Share | 0.07 |
| Working Capital | 19.04M |
Cash Flow
In the last 12 months, operating cash flow was 22.94 million and capital expenditures -34,557, giving a free cash flow of 22.91 million.
| Operating Cash Flow | 22.94M |
| Capital Expenditures | -34,557 |
| Free Cash Flow | 22.91M |
| FCF Per Share | 1.15 |
Margins
Gross margin is 100.00%, with operating and profit margins of 58.78% and 42.30%.
| Gross Margin | 100.00% |
| Operating Margin | 58.78% |
| Pretax Margin | 51.57% |
| Profit Margin | 42.30% |
| EBITDA Margin | 58.81% |
| EBIT Margin | 58.78% |
| FCF Margin | 40.96% |
Dividends & Yields
SWX:NWRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.86% |
| Shareholder Yield | -16.86% |
| Earnings Yield | 8.26% |
| FCF Yield | 8.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:NWRN has an Altman Z-Score of 4.83 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.83 |
| Piotroski F-Score | 5 |